About Us

Gary is the Founder and Chairman of Inpharmation – a company that provides a host of unique, evidence-based research techniques for pricing, forecasting, and market researching pharmaceuticals.

Gary has worked with all the world’s leading pharma companies. He has a host of awards for his conference papers and his writing. His books on pharmaceutical pricing, forecasting, market research, and the use of AI in these fields are read and referred to by pharma executives around the world.

He has trained thousands of pharma executives how to forecast and price pharmaceuticals.

Prior to founding Inpharmation, Gary held senior positions – including country manager and head of global marketing – in major pharma companies. He has degrees in medicine and management. He is a Sloan Fellow of London Business School and a Fellow of the Royal Society of Medicine.

As one of the founders, Karen’s role in Inpharmation has been to build the finance, administration, and HR teams as the company has grown.

Expert in the workings of every department, Karen has been involved in the recruitment of every person employed by Inpharmation.

Her aim is to continue to build fantastic teams by bringing fantastic people into the company.
Karen holds degrees in genetics, microbiology, and management.

Nick takes a hands-on approach to running Inpharmation’s modeling and analytics department. He is involved in every project from the beginning, through to delivery, and beyond. It is Nick who decides who in Inpharmation has the best strategic and technical knowledge to lead each project, and then chooses the best people to work within that team. Clients value the fact that Nick knows their projects intimately and is always available to speak to them.

His consulting experience is enormously wide. He has worked with all the top 20 pharma companies and the majority of the top 50. He has worked in all major therapy areas, all major HTA systems, and at all stages of the pharmaceutical lifecycle. He has worked in pricing, market access, demand forecasting, market research, behavior-based pricing, and international reference pricing.

Nick was instrumental in developing Inpharmation’s market leading international referencing software. He was one of the first people to realize, way back in 2008, that financial crises lead to pharmaceutical price cuts which cascade through the international referencing system. He has successfully guided many clients accordingly.

Nick is a sought-after speaker on pricing, market access, and international reference pricing. He delivers forecasting and pricing training courses. He co-authors papers with clients.

Nick has degrees in Molecular and Cellular Biochemistry from the University of Oxford.

He joined Inpharmation’s Board of Directors in 2021.

Kim believes that successful collaborations begin with a strong understanding of our clients’ needs and what they are ultimately trying to achieve. The key, he believes, is listening carefully, asking the right questions, building a picture. Only then can we find the right and most elegant solutions to help them. This is one of the reasons our customers choose to work with us again and again.

Over the past decade Kim has built a talented and hard-working business development team which is underpinned by his philosophy of listening to the client.

Kim is hugely experienced. He helps our customers in all areas of pharmaceutical pricing, forecasting, and market research. He has worked with most of the top 50 pharma companies across the globe and has experience in all major therapy areas and across all stages of the pharmaceutical lifecycle.

Kim has a First-Class Honours degree in Biomedical Sciences from the University of Manchester.

He joined Inpharmation’s Board of Directors in 2021.

For Harry, communication is the key to successful collaboration. He takes the time to properly understand his client’s needs before proposing solutions that will deliver on their objectives. Once there is agreement, it is Harry who helps pull together the best Inpharmation team to work on the project.

Harry has experience in pricing, forecasting, and demand research, across all major therapy areas and all stages of product development. He works with companies of all sizes from top 20 global pharma to niche biotechs.

He has a first-class bachelor’s degree in Medical Engineering and a master’s, with merit, in Nanomedicine from Swansea University.

Before joining Inpharmation, Mark developed his commercial acumen working in early-drug discovery at GlaxoSmithKline.

Mark’s strong background in pharmaceuticals is invaluable in his role with Inpharmation. Often the first point of contact with clients, Mark focuses on understanding exactly what his clients are trying to achieve and then works with them to find the best solution. He has helped clients with products in all the major therapy areas and at all stages of the product lifecycle.

Mark prides himself in exceeding customer expectations, and has a master’s in pharmacology from the University of Aberdeen.

Harshni has extensive experience leading pricing, reimbursement and market access, demand forecasting, market research, and international reference pricing projects. She has worked with most of the top 20 pharma companies and many of the top 50. She has delivered projects in all major therapy areas, at all stages of the pharmaceutical lifecycle, and in all major HTA systems.
Harshni is known for delivering high-quality projects to tight deadlines. Successful projects depend on liaising closely with customers from the outset and ensuring everyone on the team understands the brief – and then making sure everyone keeps communicating. This is Harshni’s forte.

She is a natural problem solver and comes up with some very elegant research and modeling solutions.

Harshni has a master’s in Chemistry with Medicinal Chemistry from Imperial College London.

Blythe has consulted for many of the top 20 and top 50 pharma companies. She is experienced in pricing, reimbursement and market access, demand forecasting, market research, and international reference pricing projects.

In addition to her modeling and analytical skills, Blythe is responsible for the day-to-day management of projects. This requires a blend of problem solving, operations management, liaising, and coordinating to keep everyone informed and on track. In projects with built-in decision points, it is Blythe’s job to explore all the options with our clients to help them make the best possible decisions. She has a strong track record of finding ways to make things more efficient and our customers’ lives easier.

Blythe has extensive experience delivering projects to clients and training them to use our programs, models, and market simulators. She has co-authored papers with abstracts presented at ISPOR.

She has a master’s in Chemistry for Drug Discovery from the University of Bath.

Rickie is known for his modeling expertise and his eye for detail. He leads the team responsible for developing our innovative contracting simulators. This requires in-depth knowledge of the latest trends and the ability to build these into user-friendly, customized models.

Clients ask to work with Rickie because they know he will deliver an excellent project on time. They like his calm approach and that he keeps them fully informed at every stage. When they have important decisions to make, Rickie is particularly good at exploring options with them.

Rickie has a wealth of experience. He has worked with many of the top 50 pharmaceutical companies across all the major therapy areas. He has led projects in pricing, demand forecasting, market access, international reference pricing, and value-based agreements.

Rickie has a degree in Chemistry from Imperial College London.

Emma’s consulting experience has made her an expert in market research. She also is the international reference pricing technical point-of-contact for many clients and is a clear communicator, able to easily identify and resolve misunderstandings.

Emma is the head of Inpharmation’s internal stakeholder mapping team due to her skill of identifying the right respondents for a project; she leads major projects involving payers, patients, doctors etc. across the world, and works across all major therapy areas.

Emma makes the process of market research easy and accurate by expertly identifying what data is required, formulating clear and unbiased market research questions, and interpreting the results coherently. She has a wealth of knowledge surrounding the major causes of error in pharma market research and knows how to avoid them.

Emma holds a master’s degree in Molecular and Cellular Biochemistry from the University of Oxford.

Charlotte has built a reputation for delivering top-quality projects. She is the training and technical point of contact for many clients who rely on our international reference pricing simulators. Internally, she is responsible for updating our market research simulator which is a key deliverable for our pricing and demand market-research projects.

Charlotte has worked across all major therapy areas and has consulted for many of the top 50 pharma companies. She is experienced in pricing, reimbursement and market access, demand forecasting, and market research.

She has a degree in Biomedical Engineering from Imperial College London.